Oragenics Inc (OGEN) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

OGEN ranks #8651 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

OGEN is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

18 institutions disclose a position in OGEN, but none treat it as a major bet — even Geode Capital Management, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

OGEN reported a net loss of $10.1M over the trailing twelve months.

• Not yet profitable — net loss of $10.1M over the trailing twelve months
• Revenue declined 71.4% year over year
• Net income improved year over year, from -$10.3M to -$10.1M
• Operating cash flow was negative, using $9.2M in cash
• Liabilities run 418.25x equity — a highly leveraged balance sheet worth noting